A case of imiquimod-induced alopecia

Abstract

Imiquimod cream 5% is an immune modifier approved for the treatment of genital warts, actinic keratosis, and basal cell carcinoma. This case report presents an isolated case of telogen effluvium after 6weeks of imiquimod treatment for an actinic keratosis on the scalp. Based on this case presentation, telogen effluvium is a potential rare side effect from imiquimod treatment.

Keywords::

• alopecia
• drug-induced hair loss
• imiquimod
• telogen effluvium

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.